CGC - Canopy Growth Corporation

NYSE - NYSE Delayed Price. Currency in USD
31.02
-0.38 (-1.21%)
At close: 4:02PM EST

31.20 +0.18 (0.58%)
After hours: 4:36PM EST

Stock chart is not supported by your current browser
Previous Close31.40
Open31.46
Bid31.16 x 1100
Ask31.22 x 1400
Day's Range30.21 - 32.17
52 Week Range16.74 - 59.25
Volume4,550,494
Avg. Volume12,408,268
Market Cap10.633B
Beta (3Y Monthly)2.33
PE Ratio (TTM)N/A
EPS (TTM)-1.79
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?
    Zacks6 hours ago

    Cronos-Altria Deal Boost Marijuana ETF: Will This Continue?

    Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?

  • Who's Next After Canopy Growth's and Cronos Group's Huge Deals?
    Motley Fool5 hours ago

    Who's Next After Canopy Growth's and Cronos Group's Huge Deals?

    More big cannabis industry deals could be on the way. But which marijuana producers are the top candidates to partner with major companies outside of the industry?

  • ACCESSWIRE7 hours ago

    Cannabis Stocks On The Rise After Latest Industry Boost

    CORAL GABLES, FL / ACCESSWIRE / December 10, 2018 / Marijuana stocks remain in the spotlight. CBD or cannabidiol is derived from the cannabis plant but has none of the psychotropic effects of THC. Four leading cannabis stocks to watch after this big development: Premier Health Group (PHGRF) (PHGI), New Age Beverages (NBEV), Aphria (APHA), and Canopy Growth (CGC) (WEED.TO).

  • Are Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?
    Zacks8 hours ago

    Are Options Traders Betting on a Big Move in Canopy Growth (CGC) Stock?

    Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.

  • 7 Events That Shaped Canopy Growth's 2018
    Motley Fool8 hours ago

    7 Events That Shaped Canopy Growth's 2018

    This helps to explain why Canopy is the largest marijuana stock by market cap.

  • ACCESSWIRE10 hours ago

    Today's Research Reports on Trending Tickers: CV Sciences and Canopy Growth

    NEW YORK, NY / ACCESSWIRE / December 10, 2018 / U.S. stocks closed in the red on Friday as U.S. jobs report fell short of expectations and uncertainty over the U.S. -China trade talk spur markets lower. ...

  • Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think
    Motley Foolyesterday

    Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think

    There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.

  • 4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
    Motley Fool2 days ago

    4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt

    Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.

  • Marijuana producer Aphria’s stock rebounds after second short-seller report
    MarketWatch2 days ago

    Marijuana producer Aphria’s stock rebounds after second short-seller report

    Embattled Canadian marijuana producer Aphria Inc. saw its U.S.-listed shares rebound Thursday, after the company issued a rebuttal to a series of accusations leveled by a short seller even as new allegations were posted.

  • What the Future Holds for Canopy Growth Stock
    InvestorPlace3 days ago

    What the Future Holds for Canopy Growth Stock

    With the stock market under pressure, not many investors are flocking to speculative holdings like Canopy Growth (NYSE:CGC). Specifically, Canada’s decision to legalize recreational marijuana use in mid-October caused a temporary spike, which was eventually sold into as the overall market came under pressure. Is Canopy Growth Stock a Good Company?

  • InvestorPlace3 days ago

    What Cronos Stock Investors Should Do After the Altria Buyout

    Earlier this week, Cronos (NASDAQ:CRON) put out a press release confirming that tobacco company Altria Group (NYSE:MO) was considering an investment in the company, but that no decision was finalized. Altria announced a massive move into the tobacco space. It decided to make a C$2.4 billion ($1.8 billion) strategic investment into Cronos, confirming the earlier rumors.

  • Weed CEO: 'Edibles suffer from 3 major problems'
    Yahoo Finance3 days ago

    Weed CEO: 'Edibles suffer from 3 major problems'

    Edibles still quite aren't mainstream for various reasons, an edibles CEO tells Yahoo Finance recently on the Final Round.

  • Stocks tumble, oil surges on OPEC deal
    Yahoo Finance3 days ago

    Stocks tumble, oil surges on OPEC deal

    Yahoo Finance's LIVE market coverage and analysis, beginning each day at 11:30 a.m. ET.

  • ACCESSWIRE3 days ago

    Marijuana Stocks Sparking Interest From Investors On Friday

    CORAL GABLES, FL / ACCESSWIRE / December 7, 2018 / No question about it, Cronos Group and Altria closing a multi billion dollar investment deal has sparked interest in marijuana stocks once again. Altria now joins the ranks of Constellation Brands (STZ), Molson Coors (TAP), and potentially many other non-cannabis companies to throw big bucks into the industry. Marijuana stocks to watch: Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI), Canopy Growth (CGC) (WEED.TO), Tilray (TLRY), and Aphria (APHA).

  • Tobacco giant Altria makes massive bet on cannabis
    Yahoo Finance3 days ago

    Tobacco giant Altria makes massive bet on cannabis

    Tobacco giant Altria announced a $1.8 billion (C$2.4 billion) investment in cannabis company Cronos Group.

  • MarketWatch3 days ago

    Altria to invest C$2.4 billion in Canadian cannabis company Cronos

    Canadian cannabis company Cronos Group Inc. said Friday that tobacco giant Altria Group Inc. has agreed to make a C$2.4 billion ($1.8 billion) equity investment in the company to provide the capital to help it expand and innovate. As part of the deal, Altria will receive warrants that if fully exercised would grant the company an additional C$1.4 billion. Altria will have a roughly 45% ownership stake in the company that would climb to 55% if the warrants are exercised. "This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position the Company to compete, scale and lead the rapidly growing global cannabis industry," Cronos said in a statement. The new legal Canadian cannabis market is attracting investment from a range of players, including a $4 billion investment from Constellation Brands Inc. in Canopy Growth Corp. . Cronos will be Altria's exclusive partner in pursuing opportunities in the sector, said the statement. The deal is expected to close in the first half of 2019. Altria shares rose 1.1% premarket. Cronos shares were halted for the news, but have gained 35% in 2018, while the S&P 500 has gained 0.8%.

  • Market Exclusive3 days ago

    Canopy Growth Finalizes Acquisition Agreement With Storz & Bickel Gmbh & Co. KG

    Storz & Bickel GmbH & Co. KG is officially a Canopy Growth Corporation (NYSE: CGC) subsidiary. Canopy growth closed an acquisition deal for €145 million in an all-cash settlement. Through the just-completed merger, Canopy Growth will own all Storz & Bickel subsidiaries together with its IP. The acquisition is one of the largest to go down in the […] The post Canopy Growth Finalizes Acquisition Agreement With Storz & Bickel Gmbh & Co. KG appeared first on Market Exclusive.

  • From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist
    IPO-Edge.com4 days ago

    From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist

    Level Brands to Acquire cbdMD in All Stock Transaction   By John Jannarone Level Brands is betting the farm on hemp. The company, which went public in 2017 as a licensing vehicle for Kathy Ireland’s kathy ireland Worldwide, announced this week it would acquire Cure Based Development LLC, owner of consumer cannabidiol (CBD) brand cbdMD.  […]

  • Are There Any Dividend-Paying Cannabis Stocks?
    Zacks4 days ago

    Are There Any Dividend-Paying Cannabis Stocks?

    Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?

  • From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist
    IPO Edge4 days ago

    From Supermodel to Hemp? Level Brands Transforms from Kathy Ireland’s Licensing Arm to CBD Specialist

    Level Brands to Acquire cbdMD in All Stock Transaction   By John Jannarone Level Brands is betting the farm on hemp. The company, which went public in 2017 as a licensing vehicle for Kathy Ireland’s kathy ireland Worldwide, announced this week it would acquire Cure Based Development LLC, owner of consumer cannabidiol (CBD) brand cbdMD.  […]

  • GlobeNewswire4 days ago

    Canopy Rivers Enhances European Platform With Further Investment in Italy

    Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) is pleased to announce that it has increased its ownership stake in CanapaR Corp. (“CanapaR Canada”), the Canadian parent corporation of CanapaR SrL (“CanapaR Italy”), an Italy-based organic hemp production and processing platform. The investment, which increases the Company’s ownership position to 49.9%, builds upon Canopy Rivers’ international expansion strategy and positions the Company to capitalize on the expected growth in demand for cannabis and CBD derivative products in the rapidly growing European cannabis market.

  • InvestorPlace4 days ago

    Are Softgels the Promised Land for Aurora Cannabis Stock?

    It might not be the invention of the automobile or the electric light, but the Dec. 3 announcement by Aurora Cannabis (NYSE:ACB) that it has received the go-ahead from Health Canada to sell cannabis softgel capsules for both the Canadian medical and adult-use recreational markets, is excellent news for owners of ACB stock. “Following our successful receipt of our sales license for softgels, we are now ready to start providing yet another type of delivery technology for our patients and customers,” stated Shane Morris, Aurora’s SVP of product development and regulatory affairs. “Production will be scaling up in the coming weeks, which will enable us to introduce this product to all our domestic and international target markets.

  • ACCESSWIRE4 days ago

    4 Marijuana Stocks Heating Up After Latest Industry Events

    CORAL GABLES, FL / ACCESSWIRE / December 6, 2018 / Marijuana stocks are no stranger to volatility and the recent trend has been no different during the month of December. Earlier this week, a major development was revealed as Altria was said to be in talks with cannabis company, Cronos Group (CRON). In addition, the looming Farm Bill has pot stock investors looking at this latest bout of market activity to see opportunities if this Bill passes.

  • Canopy Growth Corporation announces final results of its offer to purchase Convertible Notes
    CNW Group4 days ago

    Canopy Growth Corporation announces final results of its offer to purchase Convertible Notes

    SMITHS FALLS, ON , Dec. 6, 2018 /CNW/ - Canopy Growth Corporation (WEED.TO) (CGC) (the "Company") announced today the final results of its tender offer (the "Convertible Notes Tender Offer") pursuant to which each holder (each, a "Holder") of the Company's 4.25% Convertible Senior Notes Due 2023 (the "Notes") issued pursuant to the Indenture, dated as of June 20, 2018 , among the Company, GLAS Trust Company LLC, as U.S. trustee, and Computershare Trust Company of Canada , as Canadian trustee (the "Indenture"), had the right (the "Fundamental Change Repurchase Right") to require the Company to repurchase all of such Holder's Notes, or any portion thereof that is a multiple of C$1,000 principal amount, on December 5, 2018 .

  • Canopy Growth Corporation announces final results of its offer to purchase Convertible Notes
    PR Newswire4 days ago

    Canopy Growth Corporation announces final results of its offer to purchase Convertible Notes

    SMITHS FALLS, ON, Dec. 6, 2018 /PRNewswire/ - Canopy Growth Corporation (WEED.TO) (CGC) (the "Company") announced today the final results of its tender offer (the "Convertible Notes Tender Offer") pursuant to which each holder (each, a "Holder") of the Company's 4.25% Convertible Senior Notes Due 2023 (the "Notes") issued pursuant to the Indenture, dated as of June 20, 2018, among the Company, GLAS Trust Company LLC, as U.S. trustee, and Computershare Trust Company of Canada, as Canadian trustee (the "Indenture"), had the right (the "Fundamental Change Repurchase Right") to require the Company to repurchase all of such Holder's Notes, or any portion thereof that is a multiple of C$1,000 principal amount, on December 5, 2018.